BDKRB1 and cancer: Tumors with high BDKRB1 expression exhibited immunosuppressive microenvironmental features, including enrichment of cancer-associated fibroblasts and reduced estimated CD8<sup>+</sup> T-cell infiltration, despite concurrent activation of inflammatory signaling pathways.